CVS Health Corp. buy JPMorgan Chase & Co.
Summary
This prediction ended on 31.05.25 with a price of €55.89. With a performance of 8.42%, the BUY prediction by JPMorgan_Chase___Co_ for CVS Health Corp. closed with a slight gain. JPMorgan_Chase___Co_ has a follow-up prediction for CVS Health Corp. where he still thinks CVS Health Corp. is a Buy. A total of €1.86 was paid as dividends for this prediction. JPMorgan_Chase___Co_ has 50% into this predictionCVS Health (symbol CVS) is a health care company that operates a retail pharmacy chain and offers health care services. The company is headquartered in Rhode Island, USA and has more than 9,900 locations. CVS Health operates three business segments: Pharmacy Services, Retail/LTC and Health Care Benefits. The Pharmacy Services segment offers pharmacy benefit management solutions and includes CVS Caremark, which serves more than 94 million plan members. The Retail/LTC segment operates CVS Pharmacy, the largest pharmacy chain in the United States, and provides long-term care pharmacy services through Omnicare. The Health Care Benefits segment offers a range of health insurance products and services through Aetna, which was acquired by CVS Health in 2018.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| CVS Health Corp. | 4.175% | 4.175% | 8.340% |
| iShares Core DAX® | 3,02 % | 2,20 % | 14,66 % |
| iShares Nasdaq 100 | 3,56 % | 1,33 % | 31,41 % |
| iShares Nikkei 225® | 6,62 % | 5,71 % | 49,42 % |
| iShares S&P 500 | 2,64 % | 1,01 % | 25,12 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread CVS Health Corp. diskutieren
In the thread Trading CVS Health Corp.